3Suzuki A, Brunt EM, Kleiner DE, et al. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver iniury. Hepatology, 2(111, 54:931 939.
4Dnaan G,Benichou C. Causality assessment of adverse reactions to drugs-1. A novel method based on the conclusions of international consensus meetings: application to drug induced liver injuries. J Clin EPidemiol, 1993, 46: 1323-1330.
5Maria VA, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology, 1997, 26:664 669.
6Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology, 2008, 48:169 176.
7Lammert C, Einarsson S, Saha C, et al. Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals. Hepatology, 2008, 47 :2003 2009.
8Chalasani N, Fontana RJ, Bonkovsky HI., et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology, 2008, 135: 1924 1934.
9Weiler-Normann C, Scbramm C. Drug induced liver injury and its relationship to autoinmmne hepatitis. J Hepatol, 2011, 55:747 749. H.
10eurgu6 At3:CB, Dieho|d M, Vitry F, et al. Drug-induced autoimmune hepatitis: a frequent disorder. Gut, 2(/07, 56 (Suppl 111) : A271.
